If surgery center leaders can identify and add an up-and-coming procedure to their list of approved procedures prior to their competitors doing such, they may be able to corner the market and profit ...

Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft tissue robotic surgery market heats up.

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping ...